Latest News & Events
Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa
LEXINGTON, Mass., July 05, 2022 - (PR.com) – Hemanext Inc. (“Hemanext” or the “Company”), a...
LEXINGTON, Mass., February 02, 2022, PR NEWSWIRE – Hemanext Inc. (“Hemanext” or the “Company”), a...
Hemanext ONE Becomes First Blood Processing and Storage System to Receive Standards-Compliant Seal from AABB
LEXINGTON, Mass., January 24, 2022, PR NEWSWIRE – Hemanext Inc. today announced that Hemanext...
Innovative Blood Processing and Storage System Received CE Mark Certification for Sale in European...
Current and prospective investors access to the investor Portal
COVID 19 Updates
Follow the course of COVID-19 and locate where to donate blood
View educational material and interesting presentations
Learn about the journey of red blood cells after donation including degradation that occurs during storage and discover the potential of hypoxic storage to alleviate this problem.
Numerous studies pertaining to clinical implications of storage lesion suggest a linkage to hyper-coagulability, inflammation, impaired perfusion, immuno-modulation, organ dysfunction13, and mortality14.
Learn more about Hemanext and take a closer look at our publications, studies, and posters focused on blood quality and red blood cell characterization.
Worldwide Patent Assets
Accepted Scientific Abstracts
CONNECT WITH HEMANEXT TODAY TO LEARN MORE!
We are happy to answer any questions about the company, our technology, or our research. Fill out the form below and we will connect with you!